Vergent Bioscience has launched the Phase 3 VISUALIZE 2 trial evaluating abenacianine, a tumor-activated imaging agent designed to enhance intraoperative tumor detection in lung cancer surgery. The ...
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results